Assessing the Parasight-F test in northeastern Papua, Indonesia, an area of mixed Plasmodium falciparum and Plasmodium vivax transmission.

Walter R J TaylorUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Walter R J Taylor in
Current site
Google Scholar
PubMed
Close
,
Hendra WidjajaUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Hendra Widjaja in
Current site
Google Scholar
PubMed
Close
,
Hasan BasriUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Hasan Basri in
Current site
Google Scholar
PubMed
Close
,
David J FryauffUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by David J Fryauff in
Current site
Google Scholar
PubMed
Close
,
Colin OhrtUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Colin Ohrt in
Current site
Google Scholar
PubMed
Close
,
TaufikUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Taufik in
Current site
Google Scholar
PubMed
Close
,
Emiliana TjitraUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Emiliana Tjitra in
Current site
Google Scholar
PubMed
Close
,
Stephen L HoffmanUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Stephen L Hoffman in
Current site
Google Scholar
PubMed
Close
,
Samuel BasoUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Samuel Baso in
Current site
Google Scholar
PubMed
Close
, and
Thomas L RichieUS Naval Medical Research Unit No 2, Jakarta, Indonesia. Taylorw@who.ch

Search for other papers by Thomas L Richie in
Current site
Google Scholar
PubMed
Close

User-friendly, reliable, and inexpensive methods for diagnosing malaria are needed at the primary health care level. During a randomized treatment trial, the Parasight-F test was assessed on days 0, 3, 7, and 28 against standard light microscopy of Giemsa-stained thick blood smears for diagnosing Plasmodium falciparum parasitemia in patients with P. falciparum (n = 84) or P. vivax (n = 59) malaria. The median P. falciparum parasite count on day 0 was 2,373/microL (range = 20-74,432/microL). At the start of treatment, the Parasight-F test had a sensitivity of 95.2% (80 of 84; 95% confidence interval [CI] = 88.2-98.7), and a specificity of 94.9% (56 of 59; 95% CI = 85.8-98.9). On day 7, this test showed false-positive results in 17 (16.3%) of 104 patients (95% CI = 9.8-24.9). The Parasight-F test performed well when compared with light microscopy in detecting P. falciparum parasitemia in patients presenting with clinical malaria. However, the high false-positive rate on day 7 limits its use for patient follow-up.

Save